Farmington, CT, United States of America

Giselle Cabada

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Zimmer Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giselle Cabada. Retrieved from https://idiyas.com/inventor/giselle-cabada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giselle Cabada and Bone Graft Delivery Technology.

Introduction

Giselle Cabada is an inventor associated with Farmington, Connecticut, and Zimmer GmbH. Her patent work addresses devices and methods for delivering bone material to an implantation site.

Latest Patents

Cabada is credited with 1 patent: “Bone Graft Delivery Devices and Method.” The invention describes a delivery device with a cannula and a connected cartridge. The cartridge has a base containing one or more channels designed to receive bone material, which is compacted to a smaller diameter before delivery. The method actuates the compacted material from the cartridge through the cannula and toward the implantation site.

Career Highlights

Cabada’s listed patent reflects work on bone-graft delivery technology, with a focus on handling and transferring bone material through a compact, channel-based device. She is associated with Zimmer GmbH.

Collaborations

Marton Varady is identified as Cabada’s coworker.

Conclusion

Giselle Cabada’s patent centers on a device and method for delivering compacted bone material, contributing to the development of bone-graft delivery technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…